首页 | 本学科首页   官方微博 | 高级检索  
     

等差递增肠内营养对肝门部胆管癌患者营养状况及喂养耐受性的影响
引用本文:张武爱,王展福. 等差递增肠内营养对肝门部胆管癌患者营养状况及喂养耐受性的影响[J]. 肿瘤药学, 2024, 14(1): 116-120
作者姓名:张武爱  王展福
作者单位:梧州市中医医院 营养科,广西 梧州,543002
摘    要:目的 研究等差递增肠内营养对肝门部胆管癌患者营养状况及喂养耐受性的影响。方法 选择我院收治的80例肝门部胆管癌术后患者,入组时间为2018年2月—2020年3月,所有患者分组方式为随机抽签法。其中40例为参照组,予以间歇推注法开展肠内营养支持;40例为观察组,肠内营养支持方式为等差递增输注法。参照组及观察组平均营养支持干预时间为10 d。分别于术前1 d、术后10 d检测两组患者营养状态指标前白蛋白、转铁蛋白、白蛋白水平;对两组患者采用早期肠内营养(EEN)喂养耐受性问卷调查表进行评价;检测患者术前1 d、术后10d免疫功能指标CD4+、CD8+水平,计算CD4+/CD8+比值;术后观察参照组及观察组患者并发症发生情况。结果术前1 d,参照组及观察组营养状态指标前白蛋白、转铁蛋白、白蛋白水平相比无显著差异(P>0.05);术后10 d,观察组前白蛋白、转铁蛋白、白蛋白水平明显高于参照组(P<0.05)。观察组与参照组在EEN总耐受率方面对比,前者更高(P<0.05)。术前1 d,观...

关 键 词:等差递增肠内营养输注  肝门部胆管癌  喂养耐受性  营养状况  并发症

Effect of iso-incremental enteral nutrition infusion on the nutritional status and feeding tolerance of patients with hilar cholangiocarcinoma
ZHANG Wu’ai,WANG Zhanfu. Effect of iso-incremental enteral nutrition infusion on the nutritional status and feeding tolerance of patients with hilar cholangiocarcinoma[J]. Anti-Tumor Pharmacy, 2024, 14(1): 116-120
Authors:ZHANG Wu’ai  WANG Zhanfu
Affiliation:Nutritional Department, Wuzhou Municipal Hospital of Traditional Chinese Medicine, Wuzhou, 543002, Guangxi, China
Abstract:Objective To investigate the effect of iso-incremental enteral nutrition infusion on the nutritional status and early enteral nutrition (EEN) feeding tolerance of hilar cholangiocarcinoma patients.Methods A total of 80 postoperative patients with hilar cholangiocarcinoma treated in our hospital between February 2018 and March 2020 were selected, and were randomly divided into two groups. 40 cases in the reference group got enteral nutrition support with intermittent infusion method, and 40 cases in the observation group got enteral nutrition support with the iso-incremental infusion method. The intervention time of nutritional support for both groups was averagely 10 d. The levels of nutritional status indicators such as prealbumin, transferrin, albumin of patients in both groups were detected 1 d before and 10 d after surgery. The EEN feeding tolerance questionnaire of patients in both groups was evaluated. The complications of both groups were observed after operation.Results There were no differences in the levels of prealbumin, transferrin, and albumin between the reference group and the observation group 1 d before surgery (P>0.05). However, 10 d after surgery, the levels of prealbumin, transferrin, and albumin were significantly higher in the observation group than in the reference group (P<0.05). The total tolerance rate of EEN in the observation group was higher than in the reference group (P<0.05). There were no differences in immune status indexes of CD4+, CD8+, and CD4+/CD8+ between the two groups at 1 d before surgery (P>0.05). However, 10 d after surgery, the level of CD8+ in the observation group was significantly lower than in the reference group, while the CD4+/CD8+ was significantly higher than in the reference group (P<0.05). The incidence of intraperitoneal infection in the observation group was significantly lower than in the reference group (P<0.05).Conclusion Iso-incremental enteral nutrition infusion is worthy of clinical application in patients with hilar cholangiocarcinoma, for it can improve the nutritional status, increase the EEN feeding tolerance, enhance the immune function, and reduce the risk of abdominal infection of patients.
Keywords:Iso-incremental enteral nutrition infusion  Hilar cholangiocarcinoma  Feeding tolerance  Nutritional status  Complication
点击此处可从《肿瘤药学》浏览原始摘要信息
点击此处可从《肿瘤药学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号